Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 17 results.
User Information
Export Records
  1. 1.   A selective small-molecule nuclear factor-kappa B inhibitor from a high-throughput cell-based assay for "activator protein-1 hits"
  2. Kang, M. I.; Henrich, C. J.; Bokesch, H. R.; Gustafson, K. R.; McMahon, J. B.; Baker, A. R.; Young, M. R.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2009 8(3): 571-581.
  1. 2.   Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis
  2. Matthews, C. P.; Birkholz, A. M.; Baker, A. R.; Perella, C. M.; Becky, G. R.; Young, M. R.; Colburn, N. H.
  3. Cancer Research. 2007, Mar; 67(6): 2430-2438.
  1. 3.   Low level, long-term inorganic arsenite exposure causes generalized resistance to apoptosis in cultured human keratinocytes: Potential role in skin co-carcinogenesis
  2. Pi, J. B.; He, Y. Y.; Bortner, C.; Huang, J. L.; Liu, J.; Zhou, T.; Qu, W.; North, S. L.; Kasprzak, K. S.; Diwan, B. A.; Chignell, C. F.; Waalkes, M. P.
  3. International Journal of Cancer. 2005, AUG 10; 116(1): 20-26.
  1. 4.   A paracrine signal mediates the cell transformation response to low dose gamma radiation in JB6 cells
  2. Weber, T. J.; Siegel, R. W.; Markille, L. M.; Chrisler, W. B.; Lei, X. Y. C.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2005, MAY; 43(1): 31-37.
  1. 5.   Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms
  2. Hou, D. X.; Kai, K.; Li, J. J.; Lin, S. G.; Terahara, N.; Wakamatsu, M.; Fujii, M.; Young, M. R.; Colburn, N.
  3. Carcinogenesis. 2004 25(1): 29-36.
  1. 6.   Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP- 1 transactivation
  2. Yang, H. S.; Knies, J. L.; Stark, C.; Colburn, N. H.
  3. Oncogene. 2003 22(24): 3712-3720.
  1. 7.   AP-1, NF kappa B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model
  2. Suzukawa, K.; Weber, T. J.; Colburn, N. H.
  3. Environmental Health Perspectives. 2002 110(9): 865-870.
  1. 8.   Protection against human papillomavirus type 16-E7 oncogene- induced tumorigenesis by in vivo expression of dominant- negative c-jun
  2. Young, M. R.; Farrell, L.; Lambert, P.; Awasthi, P.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2002 34(2): 72-77.
  1. 9.   Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappa B activation
  2. Hsu, T. C.; Nair, R.; Tulsian, P.; Camalier, C. E.; Hegamyer, G. A.; Young, M. R.; Colburn, N. H.
  3. Cancer Research. 2001 61(10): 4160-4168.
  1. 10.   Induced expression of dominant-negative c-jun downregulates NF kappa B and AP-1 target genes and suppresses tumor phenotype in human keratinocytes
  2. Li, J. J.; Cao, Y.; Young, M. R.; Colburn, N. H.
  3. Molecular Carcinogenesis. 2000 29(3): 159-169.
  1. 11.   Human papillomavirus and cancer: The viral transforming genes
  2. Phillips, A. C.; Vousden, K. H.; Newton, R.; Beral, V.; Weiss, R. A.
  3. Infections and Human Cancer. 1999; 33 : 55-74.
  1. 12.   Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer
  2. El Abdaimi, K.; Papavasiliou, V.; Rabbani, S. A.; Rhim, J. S.; Goltzman, D.; Kremer, R.
  3. Cancer Research. 1999 59(14): 3325-3328.
  1. 13.   Expression of Dominant Negative Jun Inhibits Elevated Ap-1 and Nf-Kappa-B Transactivation and Suppresses Anchorage Independent Growth of Hpv Immortalized Human Keratinocytes
  2. Li, J. J.; Rhim, J. S.; Schlegel, R.; Vousden, K. H.; Colburn, N. H.
  3. Oncogene. 1998 16(21): 2711-2721.
  1. 14.   Grafting Assay Distinguishes Promotion Sensitive From Promotion Resistant Jb6 Cells
  2. Strickl, J.; Sun, Y.; Dong, Z. G.; Colburn, N. H.
  3. Carcinogenesis. 1997 18(6): 1135-1138.
  1. 15.   Chemokine Production By Human Vascular Smooth Muscle Cells - Modulation By Il-13
  2. Jordan, N. J.; Watson, M. L.; Williams, R. J.; Roach, A. G.; Yoshimura, T.; Westwick, J.
  3. British Journal of Pharmacology. 1997 122(4): 749-757.
  1. 16.   Enhanced Sensitivity to Tumor Growth and Development in Multistage Skin Carcinogenesis By Transforming Growth Factor-Alpha-Induced Epidermal Growth Factor Receptor Activation But Not P53 Inactivation
  2. Shibata, M. A.; Ward, J. M.; Green, J. E.; Merlino, G.
  3. Molecular Carcinogenesis. 1997 18(3): 160-170.
  1. 17.   Lesions of Aryl-Hydrocarbon Receptor-Deficient Mice
  2. Fernandezsalguero, P. M.; Ward, J. M.; Sundberg, J. P.; Gonzalez, F. J.
  3. Veterinary Pathology. 1997 34(6): 605-614.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel